Kedaara pumps $200m into ortho support wear maker Tynor

Kedaara Capital has acquired a majority stake in Tynor Orthotics for approximately $200 million. This significant deal provides an exit for investor Lighthouse Funds from the medical device maker. Tynor Orthotics manufactures orthopaedic supports and mobility aids for global markets. The company has an extensive distribution network reaching numerous retail outlets and hospitals. Kedaara will partner with Tynor's promoters and its existing strategic partner Thuasne.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/c3aRA2F
via IFTTT

Read More

Grip strength, gait may soon measure biological lifespan, says Dr Prateek Sharma

Genes influence lifespan, but lifestyle and environment are crucial for longevity. Biological age will soon be measured by new indicators beyond chronological age. Healthy life expectancy boosts India's economy significantly, benefiting all stakeholders. The focus is shifting from lifespan to healthspan, adding energy and reducing disease. Evidence-based nutrition science is vital, dispelling myths about magic diets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wZ3IEiA
via IFTTT

Read More

Kedaara Capital bets on India’s orthopaedic market with $200 million Tynor deal

Kedaara Capital has acquired a majority stake in Tynor Orthotics for $200 million. This private equity firm is expanding its medical devices portfolio with this significant investment. Tynor Orthotics is a leading Indian manufacturer of orthopaedic and rehabilitation products. The company has a wide distribution network reaching many countries globally. Kedaara will partner with existing promoters and management to drive future growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sWElm3B
via IFTTT

Read More

Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilar

In a significant advancement, Biocon Biologics has gained marketing approval for its pegfilgrastim biosimilar in Japan. This vital cancer supportive care drug is designed to mitigate infection risks following chemotherapy. Developed as a rival to Neulasta, Sandoz KK will handle its exclusive promotion and distribution. This approval marks a pivotal step in expanding Biocon's biosimilar range and improving patient accessibility worldwide.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aHGz7cR
via IFTTT

Read More

Govt eases loan licence requirement for 'outsourced' sterilisation of medical gear

Medical device makers now avoid loan licenses for outsourced sterilization services. This change simplifies business while industry leaders express concerns about new labeling rules. Printing sterilizer license numbers on device labels may hinder export flexibility and cause shipment delays. Manufacturers worry about losing the ability to choose the fastest available sterilization facility. The government also recognized the European Union for clinical investigation waivers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gTqpi32
via IFTTT

Read More

DRL, Emcure get approval to make breakthrough HIV drug

India's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for local clinical trials. This move will improve access to the HIV prevention injection. Lenacapavir is a breakthrough twice-yearly injection for HIV prevention. Patient groups had urged the regulator to expedite this process.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uDHPmRf
via IFTTT

Read More

Adani Group to set up 2,000-bed hospital in Bengal, 1,000 beds to be free

The Adani Group plans to establish a significant 2,000-bed hospital in New Town. Half of these beds will be allocated for free treatment of the poor. West Bengal Chief Minister Suvendu Adhikari confirmed this development. He stated that Karan Adani had met him regarding the project. Gautam Adani has sent a commitment letter to begin work soon.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fwDN7Sk
via IFTTT

Read More